Everlywell and Natalist, both health and wellness companies specializing in at-home testing and reproductive health, settled a $5 million class action lawsuit over allegations of improper data sharing. The crux of the issue revolved around allegations that the companies had shared personal data and test results of their customers with third parties such as Facebook and Google through tracking technologies on their websites. This unauthorized data sharing was deemed improper and in violation of personal privacy regulations, resulting in the lawsuit. The significance of this lawsuit lies in its implications for data privacy and consumer protection in the digital age, particularly within the health and wellness industry. This case serves as a reminder of the importance of data privacy and the potential consequences of unauthorized data sharing. The settlement amount will be distributed among customers who purchased products or services from these companies between April 2019 and December 2024. The $5 million settlement fund is divided into two subclasses: one for individuals who purchased sensitive tests, such as for sexually transmitted infections, and another for those who purchased non-sensitive tests. This case echoes similar incidents in recent years, shedding light on the ongoing struggle between technological advancements and data privacy.